Medical and Pharmaceutical Novocure sees 6% spike from EU nod for electric lung cancer therapy gadget The Swiss company's Optune Lua device received FDA approval last fall Rowan DunneApril 22, 2025
Medical and Pharmaceutical Novocure scoops FDA approval for electric field lung cancer treatment device The Swiss oncology company's stock rose by over 33% as a result Rowan DunneOctober 16, 2024